Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm
MedTech Insights report series analyzes the impact of recent breakthroughs in pulsed-field ablation, signaling its promising future in the electrophysiology mapping and ablation device market LONDON, Dec. 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people an...
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development
New AI-enabled, integrated workflow provides pharma and biotech companies with comprehensive R&D insights to help minimize late-stage failures during clinical trials LONDON, Dec. 5, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intellig...
Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List
Concentration of top talent with 10 countries/regions representing over 80% of list LONDON, Nov. 15, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list ofHigh...
Clarivate Report Reveals China Challenging U.S. Research Dominance, Signaling Future Research Ambitions
Institute for Scientific Information shows China matching research productivity with excellence, diversifying its research economy and expanding its collaboration network LONDON, Oct. 31, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to in...
Clarivate Partners with EveryLibrary to Support and Nurture Libraries in the U.S.
Leveraging the strengths of the two organizations to aid libraries through dedicated resources and advocacy LONDON, Oct. 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today annou...
BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity
Three-part, in-depth analysis of biopharma investments in obesity medications highlights potential impact onpatient population historically faced with limited options LONDON, Oct. 24, 2023 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a global leader in connecting people and ...
Clarivate Renews Partnership with The Federal Library and Information Network
Strengthening U.S. government libraries with comprehensive solutions across Clarivate LONDON, Oct. 18, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today announced the renewal of i...
Clarivate Report Finds Significant Adoption of AI in IP
Different roles within the IP practice and geographies significantly diverge in their attitudes towards AI LONDON, Oct. 12, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today annou...
Clarivate Accurately Forecasts Four New 2023 Nobel Prize Laureates
75 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON, Oct. 10, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today ce...
Yale University Selects Clarivate to Provide Their Next Library Services and Discovery Platforms
Improving efficiencies and achieving more unified workflows with cloud-based Ex Libris Alma and Ex Libris Primo, both part of Clarivate LONDON, Oct. 3, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transfo...
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
Rapid acceleration in IP creation and scientific knowledge drives growing acceptance of AI and ML in drug discovery and development United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery LONDON, Sept. 27, 2023 /PRN...
Clarivate Establishes Academia & Government Innovation Incubator and Acquires Alethea, an AI Student Engagement Solution
By incubating new technology with AI capabilities such as Alethea, Clarivate will further accelerate its strategy to advance knowledge through research and education LONDON, Sept. 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intel...
Clarivate Launches AI-Powered Tool to Simplify IP Budgets and Forecasts
New tool tracks and predicts IP costs more accurately and efficiently LONDON, Sept. 20, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today launched Forecast, the next generation arti...
Clarivate Unveils Citation Laureates 2023 - Annual List of Researchers of Nobel Class
71 Citation Laureates named by the Institute for Scientific Information have gone on to receive a Nobel Prize LONDON, Sept. 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today na...
Clarivate Annual G20 Scorecard Analyzes Global Research Performance Trends Across G20 Nations
New dynamic, interactive data visualizations illuminate shifts in global research landscape and enable rapid comparative analyses LONDON, Aug. 30, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform th...
OhioLINK selects Ex Libris Alma and Primo as next library services platform
The cloud-based SaaS has demonstrated successes with complex consortial systems and will achieve OhioLINK's user-centered vision LONDON, Aug. 16, 2023 /PRNewswire/ -- OhioLINK, Ohio's academic library consortium, announces the selection of Ex Libris Alma, part of Clarivate™ (NYSE: CLVT), as the ...
Clarivate Launches Enhanced Search Powered by Generative Artificial Intelligence
Latest iteration of patent pending platform enables life sciences and pharmaceutical companies to access insights from billions of proprietary data points LONDON, Aug. 9, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they c...
Clarivate Enhances Patient Data Intelligence Solution with Addition of German Hospital Prescribing Insights
New data captures German prescribing insights providing researchers with aggregated, anonymised specialty prescribing habits across brands and diseases LONDON, July 27, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they ca...
Clarivate Releases Innovators to Watch 2023 Report
Identifies 36 companies and organizations on the cusp of Top 100 Global Innovators status LONDON, July 25, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its Innovator...
BioWorld by Clarivate Recognized for Excellence in Publishing
Suite of news services receives four 2023 APEX Awards for Publications Excellence LONDON, July 19, 2023 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, is the winn...
